Zobrazeno 1 - 10
of 743
pro vyhledávání: '"P, Opat"'
Autor:
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Li Mei Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia Ai, Ashley Beekman, Pietro R. Di Ciaccio, Michael Krigstein, Joel Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir‐Jing Ho, Tara Cochrane, Eliza A. Hawkes, Chan Y. Cheah, Stephen Opat, Gareth P. Gregory
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 709-720 (2024)
Abstract Background Despite recent advances, optimal therapeutic approaches applicable to subpopulations with primary central nervous system (CNS) lymphoma outside of clinical trials remain to be determined. Methods We performed a retrospective study
Externí odkaz:
https://doaj.org/article/a25d2050b12d409d88ac6bcc23b32d07
Autor:
Simon Fifer, Jenni Godsell, Stephen Opat, Nada Hamad, Masa Lasica, Cecily Forsyth, Louisa Morand, Erica Smeaton, Sharon Winton, Andrea Puig, Marija McGeachie
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Listening to patient voices is critical, in terms of how people experience their condition as well as their treatment preferences. This research explored the patient journey, therapy attributes and goals among treatment experience
Externí odkaz:
https://doaj.org/article/393844fe1e9649d6889941648fb36c92
Autor:
Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A. Hawkes
Publikováno v:
eJHaem, Vol 5, Iss 2, Pp 325-332 (2024)
Abstract Polatuzumab vedotin (Pola) is an approved therapy in combination with rituximab and bendamustine for relapsed or refractory diffuse large B‐cell lymphoma (RR‐DLBCL) based on positive results of the landmark phase II randomised G029365 tr
Externí odkaz:
https://doaj.org/article/66c98b4dadb44b36bd6726ca23d4156b
Publikováno v:
Applied Sciences, Vol 14, Iss 14, p 6272 (2024)
Hybrid (meat–plant) products can be a sustainable response to the increased interest in flexitarianism. Their development requires designing appropriate composition and functional properties and ensuring microbiological safety. This study aimed to
Externí odkaz:
https://doaj.org/article/2e3a6fad00c541c1a3420c286bf75161
Autor:
Yuqin Song, Keshu Zhou, Dehui Zou, Dengju Li, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Cheng Fang, Shaohui Sun, Jun Zhu
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 18643-18653 (2023)
Abstract Background We previously reported results of a pooled analysis of two zanubrutinib studies in relapsed or refractory (R/R) MCL showing better survival outcomes when zanubrutinib is used in second‐line versus later‐line. Here, we present
Externí odkaz:
https://doaj.org/article/1bc9e62404054e8489c6afc31806b1b4
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract In recent years, Bruton tyrosine kinase (BTK) inhibitors have provided significant advances in the treatment of patients with B-cell malignancies. Ibrutinib was the first BTK inhibitor to be approved, and it changed the standard-of-care trea
Externí odkaz:
https://doaj.org/article/0b8e7b52447c454692e67c1626b0b8f1
Autor:
Allison Barraclough, Shivam Agrawal, Dipti Talaulikar, Geoffrey Chong, Edward Yoo, Chan Y. Cheah, Nunzio Franco, Bianca Nguyen, Howard Mutsando, Fatima Tahir, Judith Trotman, Jing Huang, Colm Keane, Mitchel Lincoln, Tara Cochrane, Anna M. Johnston, Michael Dickinson, Stephen Opat, Zoe K. McQuilten, Erica M. Wood, Gayathri St George, Eliza A. Hawkes
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Follicular Lymphoma (FL) treatment initiation is largely determined by tumor burden and symptoms. In the pre-rituximab era, the Group d’Etude des Lymphomes Folliculaires (GELF) developed widely adopted criteria to identify high tumor burden FL pati
Externí odkaz:
https://doaj.org/article/cfa735fb9c744d6191d21946d8605230
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0308558 (2024)
As science media content creators strive for inclusivity in communication design and promotion, they must consider the influence of audiences' identities on their engagement with science media. A gender gap in viewership or "missing audience" has bee
Externí odkaz:
https://doaj.org/article/f4501867ca6641118a6e577117341d97
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.